ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of Bluebird Bio, Inc.

2025-02-21 03:45:50

(MENAFN- PR Newswire)

NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by bluebird bio, Inc. (NASDAQ: BLUE ) and its board of directors concerning the proposed acquisition of the company by Carlyle (NASDAQ: CG ) and SK Capital Partners, LP. Stockholders will receive $3.00 and a contingent value right of $6.84 for each share of bluebird bio stock that they hold. The transaction is expected to close in the first half of 2025.

If you are a stockholder of bluebird bio, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: /. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected] , or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit .

Attorney Advertising. Prior results do not guarantee a similar outcome.

SOURCE Rowley Law PLLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN21022025003732001241ID1109235766

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.